Experience With Performing Rheocarna Therapy via the Single‐Needle Method for Treatment of Chronic Limb‐Threatening Ischemia
Therapeutic Apheresis and Dialysis · 2026-12 · 30 (6) · 847-853
DOI: 10.1002/1744-9987.70161 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, online erschienen am 09.06.2026. Verfasst von Yasutaka Yamauchi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Center, Takatsu General Hospital, Kawasaki, Kanagawa, Japan. Hauptthemen laut MEDLINE: Ischemia, Blood Component Removal, Chronic Limb-Threatening Ischemia. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
This study investigated the safety and efficacy of single‐needle Rheocarna therapy for chronic limb‐threatening ischemia (CLTI) with wounds.
Methods
Six patients with CLTI involving ulcers unresponsive to revascularization underwent single‐needle Rheocarna treatment. Changes in mean low‐density lipoprotein cholesterol (LDL‐C), fibrinogen, C‐reactive protein (CRP), white blood cell (WBC) count, platelet count, blood flow, and wound improvement were compared between treatment initiation and completion.
Results
The treatment never required discontinuation due to in‐circuit coagulation or hypotension, and its safety was confirmed. After 10 treatment sessions, LDL‐C and fibrinogen removal rates were 24.3% and 24.4%, respectively. Platelet, WBC, and CRP values did not change significantly over time. Blood flow increased during treatment and posttreatment. All patients experienced wound improvement and favorable clinical outcomes.
Conclusion
Single‐needle Rheocarna therapy is effective for wound healing in CLTI. If this method applies to nondialysis patients without arteriovenous fistulas, indications for Rheocarna therapy will likely expand.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Center, Takatsu General Hospital, Kawasaki, Kanagawa, Japan.
- Department of Cardiology, Tokyo Heart Center, Osaki Hospital, Tokyo, Japan.
- Department of Clinical Engineer, Takatsu General Hospital, Kawasaki, Kanagawa, Japan.
- Department of Clinical Engineer, Tokyo Heart Center, Osaki Hospital, Tokyo, Japan.
- Department of Cardiology, Tokyo Kamata Hospital, Tokyo, Japan.
- Department of Plastic and Reconstructive Surgery, Kyorin University Hospital, Tokyo, Japan.
ORCID-Profile: Norihiko Ohura
Zitieren
APA
Yamauchi, Y., Tanaka, R., Kawahira, R., Nabeta, S., Naoi, K., Kitajima, K., Wada, A., Takagi, T., Ohura, N., & Miyamoto, A. (2026). Experience With Performing Rheocarna Therapy via the Single‐Needle Method for Treatment of Chronic Limb‐Threatening Ischemia. Therapeutic Apheresis and Dialysis, 30(6), 847-853. https://doi.org/10.1002/1744-9987.70161
Vancouver
Yamauchi Y, Tanaka R, Kawahira R, Nabeta S, Naoi K, Kitajima K, et al. Experience With Performing Rheocarna Therapy via the Single‐Needle Method for Treatment of Chronic Limb‐Threatening Ischemia. Therapeutic Apheresis and Dialysis. 2026;30(6):847-853. doi:10.1002/1744-9987.70161
BibTeX
@article{Yamauchi2026,
author = {Yamauchi, Yasutaka and Tanaka, Rie and Kawahira, Reona and Nabeta, Shingo and Naoi, Kouhei and Kitajima, Kazuhito and Wada, Akira and Takagi, Tomonari and Ohura, Norihiko and Miyamoto, Akira},
title = {Experience With Performing Rheocarna Therapy via the Single‐Needle Method for Treatment of Chronic Limb‐Threatening Ischemia},
journal = {Therapeutic Apheresis and Dialysis},
year = {2026},
volume = {30},
number = {6},
pages = {847--853},
doi = {10.1002/1744-9987.70161}
}
EUVIMED